Nektar Therapeutics
Open
74.4 -2.03
Overview
Share price change
24h
Min
73.11
Max
75.95
Income | -8.8M -45M |
|---|---|
Sales | -11M 11M |
EPS | -1.783 |
Profit margin | -413.443 |
Employees | 63 |
EBITDA | -20M -39M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +102.38% upside |
Next Earnings | 6 sie 2026 |
|---|
Market Cap | -272M 2.7B |
|---|---|
Previous open | 76.43 |
Previous close | 74.4 |
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
Nektar Therapeutics Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
12 Months Forecast
Average 153.71 USD 102.38%
High 192 USD
Low 80 USD
Based on 9 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$